Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2003
02/06/2003US20030027744 Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye
02/06/2003US20030027339 Micellar systems
02/06/2003US20030026945 Applying adhesive in pattern; absorbers
02/06/2003US20030026874 Encapsulation compositions
02/06/2003US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum
02/06/2003US20030026856 Stable, homogeneous natural product extracts containing polar and apolar fractions
02/06/2003US20030026852 Molecular iodine pharmaceutical composition
02/06/2003US20030026844 Injectable sustained release pharmaceutical composition and processes for preparing the same
02/06/2003US20030026843 Amorphous drug beads
02/06/2003US20030026842 Production of hard, dense particles
02/06/2003US20030026839 Melt-extrusion multiparticulates
02/06/2003US20030026838 Administering antagonist and antagonist removal drug
02/06/2003US20030026837 Effervescent solid composition of matter
02/06/2003US20030026836 Water soluble powders and tablets
02/06/2003US20030026835 Mixture of starch, water soluble excipients and drug; oral administering
02/06/2003US20030026834 Analgesics
02/06/2003US20030026833 Bactericide; stable, nontoxic
02/06/2003US20030026832 Controlling particle size
02/06/2003US20030026831 Complexes containing anions, cations and active materials
02/06/2003US20030026829 Analgesic patch
02/06/2003US20030026827 Additives for making novelty edible comestibles and scented products that are designed for sexual arousal
02/06/2003US20030026826 Mixture containing alcohol, emulsifiers, water and active materials
02/06/2003US20030026820 Use of a compositon containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin
02/06/2003US20030026819 Protective coating for skin
02/06/2003US20030026813 Vaccine composition and method of using the same
02/06/2003US20030026785 Genetic engineering; activation; administering bacteriophages; side effect reduction
02/06/2003US20030026767 Method to aerosolize Interferon-Gamma for lung delivery for local and systemic treatments
02/06/2003US20030026766 Administering by inhalation
02/06/2003CA2493596A1 Novel targeted delivery system for bioactive agents
02/06/2003CA2454920A1 Antigenic compositions
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003CA2419089A1 Composition comprises sustained-release fine particles for quick-disintegrating tablets in the buccal cavity and manufacturing method thereof
02/05/2003EP1281752A1 Spray-dried microbial cells
02/05/2003EP1281401A2 The medical effect of Jojoba oil
02/05/2003EP1281400A2 Pharmaceutical compositions containing ascomycin derivatives
02/05/2003EP1281398A1 Dermal compositions containing coenzyme q as the active ingredient
02/05/2003EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control
02/05/2003EP1280857A1 Wound gels
02/05/2003EP1280759A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
02/05/2003EP1280656A1 Process and press for the production of tablets
02/05/2003EP1280604A1 Media milling
02/05/2003EP1280576A2 Dispensing devices and liquid formulations
02/05/2003EP1280559A2 Acylated cyclodextrin guest inclusion complexes
02/05/2003EP1280557A1 Method for the preparation of polymeric micelle via phase separation of block copolymer
02/05/2003EP1280556A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
02/05/2003EP1280548A2 Subcutaneous administration of cagulation factor vii
02/05/2003EP1280539A2 Nontoxic vernix compositions and method of producing
02/05/2003EP1280538A2 Compositions containing molecular iodine
02/05/2003EP1280536A2 Method for treating retinal degeneration with purinergic receptor agonists
02/05/2003EP1280534A1 Torasemide-containing pharmaceutical preparations
02/05/2003EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase
02/05/2003EP1280532A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
02/05/2003EP1280529A2 Opioid antagonist containing composition for enhancing the potency or reducing adverse side effects of opioid agonists
02/05/2003EP1280521A2 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
02/05/2003EP1280520A2 Phospholipid-based powders for drug delivery
02/05/2003EP1280519A1 Microprojectile delivery system and particulate product
02/05/2003EP1280518A2 Liposome drug delivery
02/05/2003EP1280517A1 Beta-glucans encapsulated in liposomes
02/05/2003EP1280516A1 Method for transdermal or intradermal delivery of molecules
02/05/2003EP1280515A2 Pharmaceutical compositions comprising cannabis
02/05/2003EP1280514A1 Evaporative coolant comprising hydrofluorocarbons and /or hydrochlorofluorocarbons
02/05/2003EP1280507A1 Eutectic mixtures in cosmetic compositions
02/05/2003EP1280499A2 Polymeric delivery and release systems for oral care actives
02/05/2003EP1280486A1 Minimizing adverse experience associated with oxybutynin therapy
02/05/2003EP1280485A1 Improved transdermal drug patch
02/05/2003EP1223918B1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
02/05/2003EP1196187A4 Keratinocyte growth factor-2 formulations
02/05/2003EP1194145B1 Stable xylometazoline and oxymetazoline solution
02/05/2003EP1105107A4 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
02/05/2003EP1051174B1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
02/05/2003EP1003486B1 Pharmaceutical compositions containing an effervescent acid-base couple
02/05/2003EP0996429B1 Solid state solutions and dispersions of poorly water soluble drugs
02/05/2003EP0932391B1 Fusogenic liposome composition and method
02/05/2003EP0928611B1 Medical powder
02/05/2003EP0858322B1 Treatment of a coronary condition by delivery of therapeutics to the pericardial space
02/05/2003EP0841904B1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
02/05/2003EP0841903B1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
02/05/2003EP0814797B1 Parenteral pharmaceutical compositions containing alkylammonium salts of 2-arylpropionic acids
02/05/2003EP0802782B1 Prophylactic and therapeutic treatment of skin sensitization and irritation
02/05/2003EP0788351B1 Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
02/05/2003EP0331755B2 Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion
02/05/2003CN2533890Y Medicines control release apparatus through the skin
02/05/2003CN1395613A 抗微生物组合物 The antimicrobial composition
02/05/2003CN1395569A Oxazolidinone thioamides with piperazine amide substituents
02/05/2003CN1395560A Glyburide composition
02/05/2003CN1395491A Polymer blends as biodegradable matrices for preparing biocomposites
02/05/2003CN1395489A Physiologically balanced ionized acidic solution and methodology for use in wound healing
02/05/2003CN1395488A Drospirenone for hormone replacement therapy
02/05/2003CN1394652A Utilization of compound capable of biologically absorbing polymer wax and medical equipment
02/05/2003CN1394647A Shuning gel propellant injection preparation
02/05/2003CN1394634A Preparation process of fresh isatis root juice
02/05/2003CN1394613A Fat-soluble suppository containing lactobacillus and its preparation method
02/05/2003CN1394611A Arsenic trioxide (ATO) oral slow-releasing granules and its preparation method
02/05/2003CN1394609A Puerarin oral preparation and its preparation method
02/05/2003CN1394608A Injection sterile powder containing erythromycin salt and M cholinergic receptor-blocking agent and its preparation method
02/05/2003CN1394607A Buxining oral disintegrant tablet for curing angina pectoris and its preparation method
02/05/2003CN1394606A Nifedipine drop pill preparation and its making method
02/05/2003CN1394605A Nimodipine oral disintegrant tablet for curing dementia and its preparation method
02/05/2003CN1394604A Indapamide slowly-releasing tablet
1 ... 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 ... 2991